Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: The SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study
出版年份 2016 全文链接
标题
Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: The SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study
作者
关键词
-
出版物
International Journal of Stroke
Volume 11, Issue 5, Pages 565-574
出版商
SAGE Publications
发表日期
2016-03-01
DOI
10.1177/1747493016632239
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Trends in Oral Anticoagulant Choice for Acute Stroke Patients with Nonvalvular Atrial Fibrillation in Japan: The SAMURAI-NVAF Study
- (2015) Kazunori Toyoda et al. International Journal of Stroke
- Cardioembolic Stroke Is the Most Serious Problem in the Aging Society: Japan Standard Stroke Registry Study
- (2015) Yuji Kato et al. Journal of Stroke & Cerebrovascular Diseases
- Acute Reperfusion Therapy and Stroke Care in Asia After Successful Endovascular Trials
- (2015) Kazunori Toyoda et al. STROKE
- Early Recurrence and Cerebral Bleeding in Patients With Acute Ischemic Stroke and Atrial Fibrillation
- (2015) Maurizio Paciaroni et al. STROKE
- Cardioembolic Stroke Is the Most Serious Problem in the Aging Society: Japan Standard Stroke Registry Study
- (2015) Yuji Kato et al. Journal of Stroke & Cerebrovascular Diseases
- Guidelines for Pharmacotherapy of Atrial Fibrillation (JCS 2013)
- (2014) CIRCULATION JOURNAL
- Association of improved outcome in acute ischaemic stroke patients with atrial fibrillation who receive early antithrombotic therapy: analysis from VISTA
- (2014) A. H. Abdul-Rahim et al. EUROPEAN JOURNAL OF NEUROLOGY
- Global Sodium Consumption and Death from Cardiovascular Causes
- (2014) Dariush Mozaffarian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anticoagulation Intensity of Rivaroxaban for Stroke Patients at a Special Low Dosage in Japan
- (2014) Takuya Okata et al. PLoS One
- Secular Trends in Ischemic Stroke Subtypes and Stroke Risk Factors
- (2014) Chrysi Bogiatzi et al. STROKE
- Stroke prevention in atrial fibrillation: An Asian perspective
- (2014) Kang-Ling Wang et al. THROMBOSIS AND HAEMOSTASIS
- Meta-Analysis of Gender Differences in Residual Stroke Risk and Major Bleeding in Patients With Nonvalvular Atrial Fibrillation Treated With Oral Anticoagulants
- (2013) Samir B. Pancholy et al. AMERICAN JOURNAL OF CARDIOLOGY
- Risks for Stroke, Bleeding, and Death in Patients With Atrial Fibrillation Receiving Dabigatran or Warfarin in Relation to the CHADS_2 Score: A Subgroup Analysis of the RE-LY Trial
- (2013) Jonas Oldgren ANNALS OF INTERNAL MEDICINE
- Confirmation of Model-based Dose Selection for a Japanese Phase III Study of Rivaroxaban in Non-valvular Atrial Fibrillation Patients
- (2013) Masato Kaneko et al. Drug Metabolism and Pharmacokinetics
- Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
- (2013) Christian T Ruff et al. LANCET
- Edoxaban versus Warfarin in Patients with Atrial Fibrillation
- (2013) Robert P. Giugliano et al. NEW ENGLAND JOURNAL OF MEDICINE
- Relation of Gender-Specific Risk of Ischemic Stroke in Patients With Atrial Fibrillation to Differences in Warfarin Anticoagulation Control (from AFFIRM)
- (2012) Renee M. Sullivan et al. AMERICAN JOURNAL OF CARDIOLOGY
- Rivaroxaban vs. Warfarin in Japanese Patients With Atrial Fibrillation
- (2012) Masatsugu Hori et al. CIRCULATION JOURNAL
- Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF
- (2012) Graeme J Hankey et al. LANCET NEUROLOGY
- Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial
- (2012) J Donald Easton et al. LANCET NEUROLOGY
- Nonvitamin-K-Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Previous Stroke or Transient Ischemic Attack
- (2012) George Ntaios et al. STROKE
- A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation
- (2010) Ron Pisters et al. CHEST
- Dabigatran compared with warfarin in patients with atrial fibrillation and previous transient ischaemic attack or stroke: a subgroup analysis of the RE-LY trial
- (2010) Hans-Christoph Diener et al. LANCET NEUROLOGY
- Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach
- (2009) Gregory Y.H. Lip et al. CHEST
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now